Titan Pharmaceuticals Inc (TTNP)

[Doctor Detroit]

Blah, Blah, Blah...

Not much came from the call.

They should know this week whether the FDA gives them a thumbs up on the parkinsons IND. If thumbs up, they are ready to start enrolling in September. It's now characterized as a Phase 2 trial, so they are skipping Phase 1.

EU partner by the time the marketing application is filed. My sense tells me no cash upfront on that one (US sales haven't justified it)...maybe a modest payment on EU approval.

Only thing I found interesting was they are focusing further development efforts on drugs where they could have a partner/research funding on day one. They called out luriglutide for Type 2 diabetes, a non-insulin drug (Victoza) that just went off patent manufactured by Novo Nordisk (Danish company, $109 billion market cap). That would be a nice deal.